Camrelizumab Combined With Apatinib Mesylate
Clinical trial NCT05380986 · UNKNOWN
Trial details
- NCT number
- NCT05380986
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-20
- Primary completion
- 2024-05-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.